CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib | Charles Explorer

CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib

Publication at Faculty of Physical Education and Sport |

2005

Abstract

CML, BCR-ABL, molecular genetics

Person